Each person’s cancer is unique, as is their treatment journey.

However, what is not unique is the devastating impact on those living with the disease and their loved ones, as well as the struggle oncologists face in working to deliver effective patient care. In fact, this is increasingly true given only 25 percent of cancer patients benefit from the first drug they are offered in treatment.1

Now, in partnership with Quest Diagnostics, collaborating with Memorial Sloan Kettering Cancer Center (MSK), UNC Lineberger (as seen on 60 Minutes), and over 20 other leading cancer institutions, we have an opportunity to give every clinician the ability to create a unique, personalized approach for their patients.

pictogram for Faster insights

Designed to Help Advance Cancer Care

After a patient’s tumor is sequenced by Quest Diagnostics, Watson analyzes the genetic alterations found to help identify potentially treatable mutations. This analysis can help oncologists identify targeted therapies for each patient’s individual cancer. This may help reduce treatment switching and can help identify clinical trials for which the patient may be eligible based on the tumor’s genetic landscape.

pictogram for Better and more precise care

Genetic Analysis

Watson further analyzes the genetic alterations of the tumor based on evidence extracted from a vast corpus of medical literature. This includes locating relevant information from free text unstructured data, which has historically required an in-depth manual curation by a team of experts. The resulting report can help guide your personalized treatment journey.

pictogram for Better and more precise care
pictogram for Improved confidence

Improved confidence

Watson Genomics from Quest Diagnostics® recommends unbiased, evidence-based approaches based on a detailed view of the tumor’s mutations, scientific journals, and MSK’s OncoKB, a precision oncology knowledge base to help inform precision treatment options for cancer patients. Comparison of literature that may typically take medical experts weeks to prepare can now be completed in significantly less time and can help patients and cancer care teams feel more confident regarding their care plan.

If you’re a healthcare professional who wants to bring the power of personalized medicine to your practice, learn more about Watson Genomics from Quest Diagnostics.

Thousands More Patients Will Soon Be Able to Use IBM's Watson to Fight Cancer

IBM Watson Cancer Moonshot: A Big Leap Forward for Cancer Treatment

IBM and New York Genome Center’s new cancer tumor repository aims to revolutionize treatment

This is just the beginning. To stay up to date as our journey unfolds, please enter your information below. We’ll send you news around the Watson for Genomics test as it becomes available.

The information you provide to IBM, as well as the information we have collected about you indirectly, may be used by IBM for marketing purposes. Before we do so, however, we will offer you the opportunity to choose whether or not to have your information used in this way. You may at any time choose not to receive marketing materials from us by following the unsubscribe instructions included in each e-mail you may receive, by indicating so when we call you, or by contacting us directly (please refer to “Privacy Questions and Access” below).

Some of our offerings may be co-branded, that is sponsored by both IBM and third parties. If you sign up for these offerings, be aware that your information may also be collected by and shared with those third parties. We encourage you to familiarize yourself with their privacy policies to gain an understanding of the manner in which they will handle information about you.

If you choose to “Email This Page” to a friend or colleague, we will ask for their name and e-mail address. We will automatically send a one-time e-mail sharing the page you indicated, but will not use that information for other purposes. Full IBM.com online privacy statement: http://www.ibm.com/privacy/details/us/en/#section_2

1 The Case for Personalized Medicine, 4th Edition, 2014, accessed on 9/8/16, available at www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/pmc_the_case_for_personalized_medicine.pdf (PDF, 1.3MB)